BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26908717)

  • 1. Demand Creation for Polio Vaccine in Persistently Poor-Performing Communities of Northern Nigeria: 2013-2014.
    Warigon C; Mkanda P; Muhammed A; Etsano A; Korir C; Bawa S; Gali E; Nsubuga P; Erbeto TB; Gerlong G; Banda R; Yehualashet YG; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S79-85. PubMed ID: 26908717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of unmet needs to address noncompliant households during polio supplemental immunization activities in Kaduna state, 2014-2016.
    Iyal HA; Shuaib F; Dauda M; Suleiman A; Braka F; Tegegne SG; Nsubuga P; Nomhwange T; Yehualashet YG; Ishaku S; Warigon C; Zakari F; Umeh G; Samaila L; Abdullahi B; Hammanyero K; Dogo P; Adamu D; Vaz RG; Alemu W
    BMC Public Health; 2018 Dec; 18(Suppl 4):1309. PubMed ID: 30541500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign--Katsina State, Nigeria.
    Michael CA; Ashenafi S; Ogbuanu IU; Ohuabunwo C; Sule A; Corkum M; Mackay S; Storms AD; Achari P; Biya O; Nguku P; Newberry D; Bwaka A; Mahoney F;
    J Infect Dis; 2014 Nov; 210 Suppl 1():S131-5. PubMed ID: 25316827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Journalists Initiatives on Immunisation Against Polio and Improved Acceptance of the Polio Vaccine in Northern Nigeria 2007-2015.
    Warigon C; Mkanda P; Banda R; Zakari F; Damisa E; Idowu A; Bawa S; Gali E; Tegegne SG; Hammanyero K; Nsubuga P; Korir C; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S86-90. PubMed ID: 26721745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing transit polio vaccination in collaboration with targeted stakeholders in Kaduna State, Nigeria: Lessons learnt: 2014-2015.
    Musa A; Abba B; Ningi AM; Gali E; Bawa S; Manneh F; Mkanda P; Banda R; Yehuluashet YG; Tegegne SG; Umeh G; Nsubuga P; Etsano A; Shuaib F; Mohammed A; Vaz RG
    Vaccine; 2016 Oct; 34(43):5159-5163. PubMed ID: 27364095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Banda R; Korir C; Enemaku O; Corkum M; Usman S; Davis LB; Nganda Gw; Burns CC; Mahoney F; Vertefeuille JF;
    MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(46):1059-63. PubMed ID: 25412063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking community barriers to polio vaccination in Northern Nigeria: the impact of a grass roots mobilization campaign (Majigi).
    Nasiru SG; Aliyu GG; Gasasira A; Aliyu MH; Zubair M; Mandawari SU; Waziri H; Nasidi A; El-Kamary SS
    Pathog Glob Health; 2012 Jul; 106(3):166-71. PubMed ID: 23265374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polio elimination in Nigeria: A review.
    Nasir UN; Bandyopadhyay AS; Montagnani F; Akite JE; Mungu EB; Uche IV; Ismaila AM
    Hum Vaccin Immunother; 2016 Mar; 12(3):658-63. PubMed ID: 26383769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward poliomyelitis eradication - Nigeria, January 2012-September 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1009-13. PubMed ID: 24336134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.
    Musa A; Mkanda P; Manneh F; Korir C; Warigon C; Gali E; Banda R; Umeh G; Nsubuga P; Chevez A; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S91-5. PubMed ID: 26609003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding vaccine hesitancy in polio eradication in northern Nigeria.
    Taylor S; Khan M; Muhammad A; Akpala O; van Strien M; Morry C; Feek W; Ogden E
    Vaccine; 2017 Nov; 35(47):6438-6443. PubMed ID: 29031691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revised Household-Based Microplanning in Polio Supplemental Immunization Activities in Kano State, Nigeria. 2013-2014.
    Gali E; Mkanda P; Banda R; Korir C; Bawa S; Warigon C; Abdullahi S; Abba B; Isiaka A; Yahualashet YG; Touray K; Chevez A; Tegegne SG; Nsubuga P; Etsano A; Shuaib F; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S73-8. PubMed ID: 26908755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward poliomyelitis eradication - Nigeria, January 2009-June 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(26):802-7. PubMed ID: 20613703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking Vaccination Teams During Polio Campaigns in Northern Nigeria by Use of Geographic Information System Technology: 2013-2015.
    Touray K; Mkanda P; Tegegn SG; Nsubuga P; Erbeto TB; Banda R; Etsano A; Shuaib F; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S67-72. PubMed ID: 26609004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the last polio sanctuaries with Directly Observed Oral Polio Vaccination (DOPV) in northern Nigeria, (2014-2016).
    Korir C; Shuaib F; Adamu U; Bawa S; Musa A; Bashir A; Isiaka A; Ningi A; Warigon C; Richard B; Fiona B; Pascal M; Loveday N; Tegegne SG; Abdul-Aziz M; Suleiman A; Mohammed K; Corkum M; Onoka C; Nsubuga P; Yehualashet YG; Vaz RG; Alemu W
    BMC Public Health; 2018 Dec; 18(Suppl 4):1314. PubMed ID: 30541493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengthening Routine Immunization in Areas of Northern Nigeria at High Risk for Polio Transmission During 2012-2014.
    Ali D; Banda R; Mohammed A; Adagadzu J; Murele B; Seruyange R; Makam J; Mkanda P; Okpessen B; Tegegne SG; Folorunsho AS; Erbeto TB; Yehualashet YG; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S147-50. PubMed ID: 26917576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences from polio supplementary immunization activities in Anambra State, Nigeria.
    Onyeka IN; Ilika AL; Ilika FN; Umeh DC; Onyibe RI; Okoye CJ; Diden G; Onubogu CU
    Niger J Clin Pract; 2014; 17(6):808-13. PubMed ID: 25385924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping circulatory vaccine-derived poliovirus in Kaduna state by scaling up special interventions in local government areas along rivers of interest- kamacha basin experience, 2013-2015.
    Musa AI; Shuaib F; Braka F; Mkanda P; Banda R; Korir C; Tegegne SG; Abdullahi S; Umeh GC; Nomhwange TI; Iyal HA; Ishaku S; Adamu U; Damisa E; Bagana M; Gugong V; Balarabe H; Nsubuga P; Vaz RG
    BMC Public Health; 2018 Dec; 18(Suppl 4):1303. PubMed ID: 30541497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of Environmental Surveillance Toward Interruption of Poliovirus Transmission in Nigeria, 2012-2015.
    Johnson Muluh T; Hamisu AW; Craig K; Mkanda P; Andrew E; Adeniji J; Akande A; Musa A; Ayodeji I; Nicksy G; Banda R; Tegegne SG; Nsubuga P; Oyetunji A; Diop O; Vaz RG; Muhammad AJ
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S131-5. PubMed ID: 26908747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.
    Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK
    J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.